Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Revenue $1.00B 2023 Valuation $3.66B 2024 Funding $657.30M 2024 Growth Rate (y/y) 25% 2023 Revenue Sacra estimates that Noom hit $1B in ARR in 2023, growing 25% YoY with 1.5M subscribers paying anywhere from $17/month to $70/month depending on the length of their subscription renewal cycle, with revenue largely coming from Noom's core weight loss app (vs Noom Mood, its mental health app and Noom Med, its Ozempic D2C healthcare product)
Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronies disease
6 months
The variety pack includes flavors such as Caramel Sea Salt, Dark Chocolate Sea Salt, and Cinnamon Churro
This is a critical issue because many patients legal complaints say that the active ingredients in Ozempic caused them to develop this condition
US$ 25.16
US$ 24.33
US$ 28.77
